Literature DB >> 16632081

Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infection.

Carolyn A Lang1, Sue Conrad, Lyndall Garrett, Diana Battistutta, W Graham E Cooksley, Michael P Dunne, Graeme A Macdonald.   

Abstract

Quality of life has been shown to be poor among people living with chronic hepatitis C. However, it is not clear how this relates to the presence of symptoms and their severity. The aim of this study was to describe the typology of a broad array of symptoms that were attributed to hepatitis C virus (HCV) infection. Phase 1 used qualitative methods to identify symptoms. In Phase 2, 188 treatment-naïve people living with HCV participated in a quantitative survey. The most prevalent symptom was physical tiredness (86%) followed by irritability (75%), depression (70%), mental tiredness (70%), and abdominal pain (68%). Temporal clustering of symptoms was reported in 62% of participants. Principal components analysis identified four symptom clusters: neuropsychiatric (mental tiredness, poor concentration, forgetfulness, depression, irritability, physical tiredness, and sleep problems); gastrointestinal (day sweats, nausea, food intolerance, night sweats, abdominal pain, poor appetite, and diarrhea); algesic (joint pain, muscle pain, and general body pain); and dysesthetic (noise sensitivity, light sensitivity, skin problems, and headaches). These data demonstrate that symptoms are prevalent in treatment-naïve people with HCV and support the hypothesis that symptom clustering occurs.

Entities:  

Mesh:

Year:  2006        PMID: 16632081     DOI: 10.1016/j.jpainsymman.2005.08.016

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  31 in total

Review 1.  Integration of palliative care in end-stage liver disease and liver transplantation.

Authors:  Jamie Potosek; Michael Curry; Mary Buss; Eva Chittenden
Journal:  J Palliat Med       Date:  2014-11       Impact factor: 2.947

2.  Somatic symptoms and the association between hepatitis C infection and depression in HIV-infected patients.

Authors:  Jeanie C Yoon; Paul K Crane; Paul S Ciechanowski; Robert D Harrington; Mari M Kitahata; Heidi M Crane
Journal:  AIDS Care       Date:  2011-05-23

Review 3.  Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?

Authors:  Donna M Evon; Carol E Golin; Michael W Fried; Francis J Keefe
Journal:  J Consult Clin Psychol       Date:  2012-06-25

4.  Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatment.

Authors:  Donna M Evon; Carol E Golin; Paul Stewart; Michael W Fried; Shani Alston; Bryce Reeve; Anna S Lok; Richard K Sterling; Joseph K Lim; Nancy Reau; Souvik Sarkar; David R Nelson; K R Reddy; Adrian M Di Bisceglie
Journal:  Contemp Clin Trials       Date:  2017-03-22       Impact factor: 2.226

Review 5.  Palliative care for patients with end-stage liver disease.

Authors:  Anne M Larson
Journal:  Curr Gastroenterol Rep       Date:  2015-05

6.  Psychometric assessment of health-related quality of life and symptom experience in HIV patients treated with antiretroviral therapy.

Authors:  Christophe Lalanne; Andrew R Armstrong; Susan Herrmann; Sophie Le Coeur; Patrizia Carrieri; Olivier Chassany; Martin Duracinsky
Journal:  Qual Life Res       Date:  2014-12-07       Impact factor: 4.147

7.  The Symptom Experience of HIV/HCV-Coinfected Adults.

Authors:  Carol Bova; Carol Jaffarian; Pauline Himlan; Linda Mangini; Lisa Ogawa
Journal:  J Assoc Nurses AIDS Care       Date:  2008 May-Jun       Impact factor: 1.354

8.  Role of Sleep Disturbance in Chronic Hepatitis C Infection.

Authors:  Meghan D Carlson; Robin C Hilsabeck; Fatma Barakat; William Perry
Journal:  Curr Hepat Rep       Date:  2010-02-20

9.  Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy.

Authors:  D M Evon; J Amador; P Stewart; B B Reeve; A S Lok; R K Sterling; A M Di Bisceglie; N Reau; M Serper; S Sarkar; J K Lim; C E Golin; M W Fried
Journal:  Aliment Pharmacol Ther       Date:  2018-01-29       Impact factor: 8.171

10.  Complementary and alternative medicine use by patients chronically infected with hepatitis C virus.

Authors:  Colin P White; Gerilynn Hirsch; Sunil Patel; Fatin Adams; Kevork M Peltekian
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.